- My Account
- Buy your own 360
- Stemrad 360 Civilian HomePage
- Stemrad 360 HomePage
- Explosive Ordinance Disposal
- Nuclear Industry
- First responder
- PRESS ROOM
- THE SCIENCE
- HOW TO BUY
- About Us
Col. (res.) Eli Passi, BA
Chairman of the Board
Mr. Passi is a retired Colonel of the Israeli Air Force, with extensive experience managing large-scale operations, and 10 years of experience in the high-tech industry.
Dr. Alex Gurevich
Dr. Gurevich received his Ph.D. in Mathematics from the University of Chicago, and is the former Head of Global Macro Trading at JPMorgan Chase.
Mr. Daniel Levitt, BA, MSM
Co-Founder, Board Member & President
Mr. Levitt co-founded StemRad in November 2011, and is a serial entrepreneur with over 23 years of senior management experience, CEO/Co-founder of 6 high-technology and life-sciences companies. Daniel was the CEO of StemRad until February 2016.
Mr. Ronen Melnik, BA, MBA
Mr. Melnik is the founder and co-Managing Partner of Wanaka Capital Partners, Israel’s first Mid-Tech Venture fund.
Prof. Joseph Schlessinger, Ph.D.
Dr. Schlessinger is the Chairman of the Department of Pharmacology and the William Prusoff Professor at Yale School of Medicine and the Director of the Cancer Biology Institute of Yale University.
Dr. Oren Milstein, Ph.D.
CEO and Chief Scientific Officer
Dr. Milstein co-founded StemRad in November 2011, and has been leading R&D efforts ever since. Oren was appointed CEO in February 2016